New vaccine booster on trial in Armidale
The first Covid-19 vaccine developed in the Southern Hemisphere, which was developed by Adelaide-based company Vaxine Pty Ltd, and uses recombinant protein technology is being
The first Covid-19 vaccine developed in the Southern Hemisphere, which was developed by Adelaide-based company Vaxine Pty Ltd, and uses recombinant protein technology is being
The pressing demands of COVID have prevented some GPs from contributing to the New England GP Research Network (NEGPRN) in recent years but Tamworth Dr
Research conducted in general practice not only helps health professionals to develop new treatment options for targeted populations. It also gives patients the opportunity to
Associate Professor Dr Michelle Guppy from the New England GP Research Network collaborated in developing and delivering an online survey on preparedness, confidence and concerns of
Two CPD events are coming up in Armidale and Tamworth in the same week, both with a theme on Wound Care. Dr Luke Bookallil will
We are delighted to announce that data collection is complete for the NEGPRN Acute Wound Care Trial, and Associate Professor Michelle Guppy will be sharing
It’s not too late to register for the Wounds Australia 2022 Conference, which kicks off in Sydney on 14 September, but you had better be
Led by Professor Jennifer Martin “Cannabinoids for Symptom Control in Advanced CanceR, an OpEn Label Prospective Clinical Trial in NSW” (CARE NSW) is a clinical
The solution to chronic wounds is bleeding obvious! That’s why Wounds Australia is raising awareness and pushing for long overdue reform to aged care. “Wound
Surgery for minor skin excision procedures is common in general practice. There is evidence that early removal of dressings does not increase infection rates for